Browsing: Volume 4 Issue 3 – March 2025
Martin Kramer, Managing Partner at Ceptar Consulting, shares what’s been happening in the tertiary part of the life settlement world for this month’s Q&A.
Our March 2025 Editor’s Letter for Life Risk News Volume 4, Issue 3. We hope you enjoy the latest issue of Life Risk News.
New life insurer entrants into UK PRT market not necessarily a sign of the floodgates opening.
UK Chancellor of the Exchequer Rachel Reeves’ announcement that she wants to unshackle billions of pounds locked in defined benefit (DB) pension fund surpluses has raised questions about how such a move might impact the country’s bulk purchase annuity market.
Recent months have delivered two significant developments that could profoundly impact life expectancy for those with chronic kidney disease.
Central Bank of Ireland AIFMD Q&A update delivers benefits to life settlement fund managers.
As our population ages, the significance and frequency of falls increases. This affects life expectancy as well as morbidity and mortality.
Many firms maintain a longevity risk capital model, making sure the methodology remains relevant and proportionate to the risk. We shine a spotlight on these models here, considering how they may evolve with post-pandemic data and Solvency II reforms.
W L Consulting’s Roger Lawrence offers his views on the UK’s Life Insurance Stress Test.
A new paper from Klarity and Munich Life Re US has examined physical activity data from wearable technology and tied this data to mortality risk.